Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease

Thiopurine Therapy Is Associated with Postoperative Intra-Abdominal Septic Complications in Abdominal Surgery for Crohn’s Disease

(2011) Pär Myrelid et al.   DISEASES OF THE COLON & RECTUM

Trends in Surgery for Crohnʼs Disease in the Era of Infliximab

(2010) Douglas W. Jones et al.   ANNALS OF SURGERY

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

(2010) Basil S. Nasir et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Small bowel resection rates in Crohnʼs disease and the indication for surgery over time: Experience from a large tertiary care center

(2009) Mark Lazarev et al.   INFLAMMATORY BOWEL DISEASES

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY